Description

Shivering is a normal physiologic response that may limit the level of therapeutic hypothermia that can be achieved. Kimberger et al identified interventions that can reduce the body temperature at which shivering is triggered, thus allowing more effective hypothermia. The authors are from the University of Bern in Switzerland and the University of Louisville.


 

Interventions that can reduce the body temperature at which shivering is triggered:

(1) therapy with moderate doses of meperidine (Demerol) in combination with

(2) skin surface warming

 

Dosing target for meperidine: plasma concentration 0.9 µg/mL

 

The combination was used to reduce the shivering threshold to just under 34°C, with minimal sedation and no respiratory depression.

 

Absolute contraindications to use of meperidine:

(1) hypersensitivity to meperidine

 

Relative contraindication to use of meperidine, or reasons for discontinuation:

(1) renal insufficiency (results in accumulation of the toxic metabolite norpethidine)

(2) toxicity due to prolonged or high dose therapy

 


To read more or access our algorithms and calculators, please log in or register.